Building an International Medical-Health-Tourism Consumption Hub: Launching a Global Cooperation Platform for High-End Healthcare Services
VCBeat has learned that the GHCF (Global Healthcare Consumption Forum) will be held for the first time during the 2022 China International Consumer Products Expo, aiming to establish a leading platform for healthcare and health tourism consumption. As one of the highlights of this year’s GHCF, the People’s Daily Online – People’s Data Research Institute will also release the annual “Report on Recommended International Brands with Influence in Medical Consumption.”
The 2022 China International Consumer Products Expo, co-hosted by the Ministry of Commerce of the People's Republic of China and the People's Government of Hainan Province, will be held in Haikou from April 12 to 16. In accordance with the overall arrangements for this year’s Expo, the supporting Global Healthcare Consumption Forum will be held concurrently during the event.
Building a Grand Stage to Amplify China’s Voice in the Global Healthcare Consumer Market
According to the organizer’s representative, the Global Healthcare Consumption Forum will be committed to the principles of internationalization, branding, openness, and innovation, striving to build an influential premier forum in the fields of global healthcare services and health tourism consumption.
By partnering with professional associations in the international medical tourism sector and collaborating with the World Medical Tourism & Global Health Congress, the forum will be held during the China International Consumer Products Expo. It will invite senior government officials, experts in the consumer healthcare field, and CEOs of leading international brands in consumer healthcare to participate in thematic forums, the opening keynote conference, ranking announcements, signing ceremonies for cooperative projects, and customized roundtable discussions. These initiatives aim to deeply explore current trends and hotspots in the international consumer healthcare market, thereby driving the development of the consumer healthcare industry in China, particularly in Hainan.
Currently, the upgrading of market demand in China is inevitably forcing supply-side reforms, with the growing middle- and high-income population driving the development of the mid-to-high-end medical market. Under the combined effects of consumption upgrades, policy liberalization, and capital infusion, the high-end medical services and health tourism markets have entered a new stage of development. Since 2018, the number of domestic high-end medical brands in China has exceeded 300, with service coverage extending across first-tier cities and selected second-tier cities nationwide; Beijing, Shanghai, Guangzhou, Shenzhen, and Boao in Hainan have emerged as their primary markets. From 2020 to 2022, the outbreak of the pandemic subjected the global medical and health consumer market to headwinds, leading to a repatriation of healthcare consumption and accelerating iterative evolution and innovative collaboration within the industry.
Release the Annual List of Consumer Healthcare to Set Industry Benchmarks
The release of the annual “International Consumer Healthcare Influential Brands” list is a highlight of this year’s GHCF Forum. The forum will jointly release the 2021 “Report on the Promotion and Evaluation of International Consumer Healthcare Influential Brands” in collaboration with the People’s Daily Online – People’s Data Research Institute.
Leveraging the robust “National Cloud” technical capabilities accumulated by People’s Daily and People’s Daily Online in the fields of informatization and big data, the People’s Data Research Institute conducts research on the consumer healthcare sector based on relevant policy-related public opinion and industry development big data. This initiative aims to provide insights into the overall development of the consumer healthcare industry, establish industry benchmarks, and promote outstanding brand case studies.
The ranking selection strictly adheres to the principles of public welfare, openness, and transparency. Compiled based on publicly available internet data and information submitted by participating organizations, it conducts systematic research into key dimensions such as technological innovation, service innovation, health consumption culture, public awareness, reputation and image, and brand influence. By leveraging retrieved public data and established criteria, the report identifies top-tier brand benchmarks and high-growth enterprises across ten major categories, culminating in the release of the “International Consumer Healthcare Brand Influence Recommendation and Evaluation Report.”
By releasing brand rankings, we select outstanding brands in the industry, establish benchmark images, and thereby break down information barriers in the consumer healthcare sector. This promotes standardized industry development, encourages the consumer healthcare sector to return to its essential health-focused nature, supports enterprises in technological innovation, continuously raises technical standards and capabilities, and drives high-quality industry growth.
Evaluation Framework for Influential Enterprises in Healthcare Consumption
We have learned from the conference organizing committee that the “2021 International Consumer Healthcare Influence Brand Recommendation and Evaluation Report” has entered the stage of re-evaluation survey and comprehensive assessment.
Compilation of Recommended Evaluation Indicators for Influential Enterprises at the Global Medical Consumption Forum of the 2022 China International Consumer Products ExpoThe compilation of recommended evaluation indicators for influential enterprises at the Global Medical Consumption Forum of the 2022 China International Consumer Products Expo will assess companies from three perspectives: technological innovation, communication impact, and growth performance. Relevant evaluation data will be aggregated from channels including recommendations by industry associations and professional institutions, corporate business registration information, media coverage, and re-evaluation surveys of shortlisted enterprises. The final output will be a list of recommended enterprises within sub-sectors, specifically categorizing candidate companies into ten major industries: pharmaceutical consumption, consumer healthcare institutions, nutritional and health supplements, health consumption services, digital medical platforms, genetic testing, assisted reproduction, medical technology devices, anti-aging medical aesthetics, and medical-health tourism consumption. Within each industry category, enterprises are classified into three types: domestic and international influence, growth-oriented, and innovation-driven. The growth dimension focuses on corporate development and expansion, while the innovation dimension emphasizes scientific research and technological capabilities.
Corporate Evaluation Results= Coefficient A * Impact + Coefficient B * Innovation + Coefficient C * Growth
Based on corporate innovation performance, the top five companies in innovation scores are listed as members of the Innovation Ranking.
Based on corporate growth performance, the top five companies by growth score are listed as members of the Growth Ranking.
The final scores for outstanding enterprises shall incorporate expert opinions and integrate data results to form the final list of influential brand enterprises.
The 2022 EXPO is co-hosted by the Ministry of Commerce of China and the People’s Government of Hainan Province. The guiding unit for the GHCF – Global Healthcare Consumption Forum is the Health Commission of Hainan Province, with the Hainan International Economic Development Bureau as the supporting unit. It is jointly organized by the Administration Bureau of Boao Lecheng International Medical Tourism Pilot Zone, the World Medical Tourism and Global Health Conference, and Hainan First Chengmei Medical Group. People’s Daily Online – People’s Data Research Institute serves as the publisher of the “2021 International Consumer Healthcare Influential Brand Recommendation and Evaluation Report.” The event is co-undertaken by the Hainan Free Trade Port International Cooperation Medical Health Tourism Promotion Center and Bosishangtong Global Medical Health Resources Group, with Beijing Bosishangtong Information Co., Ltd. responsible for planning and execution.
Scan or click the link to view the introduction to the ranking evaluation campaign
Link:http://lxi.me/p1pot
Scan or click the link to view the introduction to the Global Healthcare Consumption Forum